Malekzadeh, R., Abedini, A., Mohsenpour, B., Sharifipour, E., Ghasemian, R., Javad-Mousavi, S. A., . . . Tabarsi, P. (2020). Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial. Int Immunopharmacol.
Citação norma ChicagoMalekzadeh, Reza, et al. "Subcutaneous Tocilizumab in Adults With Severe and Critical COVID-19: A Prospective Open-label Uncontrolled Multicenter Trial." Int Immunopharmacol 2020.
Citação norma MLAMalekzadeh, Reza, et al. "Subcutaneous Tocilizumab in Adults With Severe and Critical COVID-19: A Prospective Open-label Uncontrolled Multicenter Trial." Int Immunopharmacol 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.